Search Results - "Bander, Jeffrey"

Refine Results
  1. 1

    Retrospective analysis of demographic factors in COVID-19 patients entering the Mount Sinai Health System by Eskandari, Abrisham, Brojakowska, Agnieszka, Bisserier, Malik, Bander, Jeffrey, Garikipati, Venkata Naga Srikanth, Hadri, Lahouaria, Goukassian, David, Fish, Kenneth

    Published in PloS one (16-07-2021)
    “…With the continued rise of the global incidence of COVID-19 infection and emergent second wave, the need to understand characteristics that impact…”
    Get full text
    Journal Article
  2. 2

    Comorbidities, sequelae, blood biomarkers and their associated clinical outcomes in the Mount Sinai Health System COVID-19 patients by Brojakowska, Agnieszka, Eskandari, Abrisham, Bisserier, Malik, Bander, Jeffrey, Garikipati, Venkata Naga Srikanth, Hadri, Lahouaria, Goukassian, David A, Fish, Kenneth M

    Published in PloS one (06-07-2021)
    “…With the continuing rise of SARS-CoV2 infection globally and the emergence of various waves in different countries, understanding characteristics of…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Renal cell carcinoma with inferior vena cava thrombus extending to the right atrium diagnosed during pregnancy by Ghanney, Efe C., Cavallo, Jaime A., Levin, Matthew A., Reddy, Ramachandra, Bander, Jeffrey, Mella, Maria, Stone, Joanne, Schwartz, Myron, Haines, Kenneth, Gidwani, Umesh, Mehrazin, Reza

    Published in Therapeutic Advances in Urology (01-06-2017)
    “…Only one case of renal cell carcinoma (RCC) with inferior vena cava (IVC) tumor thrombus diagnosed and treated during pregnancy has been reported in the…”
    Get full text
    Book Review Journal Article
  6. 6

    Clinical Implications of SARS-CoV-2 Interaction With Renin Angiotensin System: JACC Review Topic of the Week by Brojakowska, Agnieszka, Narula, Jagat, Shimony, Rony, Bander, Jeffrey

    “…Severe acute respiratory-syndrome coronavirus-2 (SARS-CoV-2) host cell infection is mediated by binding to angiotensin-converting enzyme 2 (ACE2). Systemic…”
    Get full text
    Journal Article
  7. 7

    Plasma Transforming Growth Factor-β1 (TGF-β1) Levels Increase with Age and Aortic Stenosis Progression and Low-Dose Galunisertib Attenuates Disease Progression in Mice by Subramani, Kumar, Varshney, Rohan, Subramanian, Sandeep, Bander, Jeffrey, Babii, Denys, Ahamed, Jasimuddin

    Published in Blood (02-11-2023)
    “…Objective: Aortic stenosis (AS) is an age-related degenerative valvular disease that ultimately leads to heart failure and sudden death. Platelet-derived…”
    Get full text
    Journal Article
  8. 8

    Abstract 4140246: AI and Quantum Sensors: Realization of a Safe and Effective Unshielded Bedside Magnetocardiogram to Detect Ischemia in the Emergency Room by Iwata, Geoffrey, Aschbacher, Kirstin, John, Sajiny, Tam, Simon, Au-Yeung, Kit Yee, Contreras, Johanna, Bhatt, Deepak, Bander, Jeffrey

    Published in Circulation (New York, N.Y.) (12-11-2024)
    “…Abstract only Introduction: Magnetocardiography (MCG) has potential to significantly improve cardiac disease diagnosis, but adoption in clinical practice is…”
    Get full text
    Journal Article
  9. 9

    Clinical Implications of SARS-CoV-2 Interaction With Renin Angiotensin System by Brojakowska, Agnieszka, Narula, Jagat, Shimony, Rony, Bander, Jeffrey

    “…Severe acute respiratory-syndrome coronavirus-2 (SARS-CoV-2) host cell infection is mediated by binding to angiotensin-converting enzyme 2 (ACE2). Systemic…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Clinical Implications of SARS-CoV-2 Interaction With Renin Angiotensin System: Review Topic of the Week by Brojakowska, Agnieszka, Narula, Jagat, Shimony, Rony, Bander, Jeffrey

    “…Severe acute respiratory-syndrome coronavirus-2 (SARS-CoV-2) host cell infection is mediated by binding to angiotensin-converting enzyme 2 (ACE2). Systemic…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15

    Outcomes of Impella‐supported high‐risk nonemergent percutaneous coronary intervention in a large single‐center registry by Azzalini, Lorenzo, Johal, Gurpreet S., Baber, Usman, Bander, Jeffrey, Moreno, Pedro R., Bazi, Lucas, Kapur, Vishal, Barman, Nitin, Kini, Annapoorna S., Sharma, Samin K.

    “…Objectives We aimed to evaluate the early and one‐year outcomes of Impella‐supported high‐risk nonemergent percutaneous coronary intervention (PCI). Background…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20